Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Cost of Revenue (2011 - 2026)

Vericel (VCEL) posted Cost of Revenue of $21.1 million for Q2 2026, up 9.9% sequentially from $19.2 million in Q1 2026, and up 26.63% YoY from $16.6 million in Q2 2025.

Analysis

Vericel (VCEL) Cost of Revenue (2011 - 2026) Analysis & Trends

Vericel has reported Cost of Revenue for 16 years, with the latest figure at $21.1 million in Q2 2026.

  • Quarterly Cost of Revenue rose 26.63% year-over-year to $21.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $77.9 million (up 17.92% YoY) and the FY2025 annual result came in at $70.7 million, up 8.51% from the prior year.
  • Cost of Revenue rose to $21.1 million in Q2 2026 per VCEL's latest filing, from $19.2 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $21.1 million in Q2 2026 and troughed at $12.6 million in Q1 2022.
  • A 5-year average of $16.3 million and a median of $16.2 million in 2024 frame the typical range for Cost of Revenue.
  • The sharpest annual moves came in 2024 and 2026: Cost of Revenue advanced 0.5% in 2024, then climbed 26.63% in 2026.
  • Over 5 years, Cost of Revenue stood at $14.4 million in 2022, then increased by 14.15% to $16.5 million in 2023, then advanced by 2.35% to $16.9 million in 2024, then increased by 17.26% to $19.8 million in 2025, then advanced by 6.39% to $21.1 million in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods registered $21.1 million, $19.2 million, and $19.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 489.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 360.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 145.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 93.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 174.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 298.26 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 67.21 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn 21.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.06 Mn
Mar 31, 2026 19.16 Mn
Dec 31, 2025 19.79 Mn
Sep 30, 2025 17.92 Mn
Jun 30, 2025 16.63 Mn
Mar 31, 2025 16.33 Mn
Dec 31, 2024 16.88 Mn
Sep 30, 2024 16.25 Mn
Jun 30, 2024 16.06 Mn
Mar 31, 2024 15.93 Mn
Dec 31, 2023 16.49 Mn
Sep 30, 2023 14.97 Mn
Jun 30, 2023 15.98 Mn
Mar 31, 2023 14.50 Mn
Dec 31, 2022 14.45 Mn
Sep 30, 2022 13.32 Mn
Jun 30, 2022 14.19 Mn
Mar 31, 2022 12.62 Mn
Dec 31, 2021 13.56 Mn
Sep 30, 2021 12.41 Mn